BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26820121)

  • 21. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
    Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference - functions as a potential tumor suppressor in breast cancer.
    Wang S; Shu JZ; Cai Y; Bao Z; Liang QM
    Asian Pac J Cancer Prev; 2012; 13(6):2813-8. PubMed ID: 22938464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7].
    Wang HL; Xiao Y; Wu L; Ma DC
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):508-513. PubMed ID: 29931899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro RNA-126 coordinates cell behavior and signaling cascades according to characteristics of breast cancer cells.
    Turgut Cosan D; Oner C; Mutlu Sahin F
    Bratisl Lek Listy; 2016; 117(11):639-647. PubMed ID: 28125889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
    Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
    Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.
    Yahya SMM; Nabih HK; Elsayed GH; Mohamed SIA; Elfiky AM; Salem SM
    Breast Cancer Res Treat; 2024 Feb; 204(1):133-149. PubMed ID: 38057687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing.
    Shi Y; Ye P; Long X
    Cell Physiol Biochem; 2017; 44(2):804-816. PubMed ID: 29176322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circASS1 is downregulated in breast cancer cells MDA-MB-231 and suppressed invasion and migration.
    Hou JC; Xu Z; Zhong SL; Zhang HD; Jiang LH; Chen X; Zhu LP; Li J; Zhou SY; Yang SJ; He YJ; Wang DD; Deng F; Zhang Q; Wang JY; Hu JH; Zhang W; Wu Y; Ding L; Zhao JH; Tang JH
    Epigenomics; 2019 Feb; 11(2):199-213. PubMed ID: 30657346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis.
    Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B
    Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
    Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
    Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences of time-dependent microRNA expressions in breast cancer cells.
    Bozkurt SB; Ozturk B; Kocak N; Unlu A
    Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of miR-143 expression could inhibit migration and growth of MDA-MB-468 cells through down-regulating the expression of invasion-related factors.
    Tavanafar F; Safaralizadeh R; Hosseinpour-Feizi MA; Mansoori B; Shanehbandi D; Mohammadi A; Baradaran B
    Biomed Pharmacother; 2017 Jul; 91():920-924. PubMed ID: 28511343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.
    Ibrahim SA; Yip GW; Stock C; Pan JW; Neubauer C; Poeter M; Pupjalis D; Koo CY; Kelsch R; Schüle R; Rescher U; Kiesel L; Götte M
    Int J Cancer; 2012 Sep; 131(6):E884-96. PubMed ID: 22573479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.